The effect of intranasal sodium cromoglycate on symptoms of suspected acute viral upper respiratory tract infection (URTI) in children
| ISRCTN | ISRCTN21562211 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN21562211 |
| Protocol serial number | G9900236 |
| Sponsor | Medical Research Council (MRC) (UK) |
| Funder | Medical Research Council (UK) |
- Submission date
- 23/10/2000
- Registration date
- 23/10/2000
- Last edited
- 13/09/2007
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Christopher C Butler
Scientific
Scientific
Department of General Practice
University of Wales College of Medicine Health Centre Maelfa
Llanedeyrn
Cardiff
CF23 9PN
United Kingdom
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Scientific title | |
| Study acronym | SAVIT Study |
| Study objectives | The trial is designed to answer the question; "In children presenting in general practice with suspected acute viral upper respiratory tract infection of less than 36 h duration, does treatment with intranasal sodium cromoglycate improve symptoms more than placebo?" |
| Ethics approval(s) | Not provided at time of registration. |
| Health condition(s) or problem(s) studied | Primary care |
| Intervention | 300 children will be randomised to receive either normal saline nose spray or sodium cromoglycate 4% nose spray every 2 h (during waking hours) for the first 2 days, and every 4 h for a further 5 days or until quite well. |
| Intervention type | Other |
| Primary outcome measure(s) |
CARIFS Scale Score |
| Key secondary outcome measure(s) |
Not provided at time of registration |
| Completion date | 31/08/2000 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | Not Specified |
| Target sample size at registration | 300 |
| Key inclusion criteria | Children aged from 6 months to 6 years with suspected acute viral URTI for less than 36 h |
| Key exclusion criteria | Children with: a history of having taken cromolyns or steroids within the previous week; carers who are incapable of giving informed consent or unable to keep symptom diaries; an established complication requiring immediate hospitalisation, or for whom the clinician plans to prescribe antibiotics at the first consultation. |
| Date of first enrolment | 01/09/1999 |
| Date of final enrolment | 31/08/2000 |
Locations
Countries of recruitment
- United Kingdom
- Wales
Study participating centre
Department of General Practice
Cardiff
CF23 9PN
United Kingdom
CF23 9PN
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | Results: | 22/06/2002 | Yes | No |